Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > SR 14968,2133455-40-8 for Sale > 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1H-benzo[d]imidazol-2(3H)-one 2133455-40-8
1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1H-benzo[d]imidazol-2(3H)-one   2133455-40-8 buy - large image1
1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1H-benzo[d]imidazol-2(3H)-one   2133455-40-8 buy - image1

1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1H-benzo[d]imidazol-2(3H)-one 2133455-40-8

22 Inquiries

Unit Price: Get Latest Price
CAS No.:

2133455-40-8

Port:

Shanghai

Packaging:

as required

Price valid (until):

2025-11-16

Company Type:
Trader
Location:
China
Qualification:
Main Products:

13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Common Name: 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1H-benzo[d]imidazol-2(3H)-one
    English Name: 1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1H-benzo[d]imidazol-2(3H)-one
    CAS Number: 2133455-40-8
    Molecular Weight: 469.2
    Density: Not Available
    Boiling Point: Not Available
    Molecular Formula: C20H20BrCl2N3O

    Basic Info
    Product Name:

    SR 14968,2133455-40-8

    CAS No.:

    2133455-40-8

  • Seller Information
    Business Type:

    Trader

    Main Products:

    13-Dimethyladamantane,1-Bromo-35-dimethyladamantane,perhydroacenaphthylene,4-[1,1-bis(4-hydroxyphenyl)ethyl]phenol,CYCLOBUTANE-1,2-DICARBOXYLIC ACID DIMETHYL ESTER, TRANS

    Location:

    Room 1623,Building A, ZhongqiaoCenter,Goverment District,Hefei city,Anhui Province,China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    5-10

    Year of Establishment:

    2019

  • Inquiry History
    22 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-5,6-dichloro-1H-benzo[d]imidazol-2(3H)-one

    10 G Dec 18, 2025
    United States

    Sr-14968

    10 G Apr 28, 2026
    United States

    Sr-14968

    100 G Apr 15, 2026
    Germany

    Sr 14968

    1 KG Mar 23, 2026
    United States

    sr-14968

    25 G Feb 7, 2026
    Germany

    SR14968

    5 MT Feb 4, 2026
    United States

    SR 14868

    5 G Dec 18, 2025
    United States

    SR-14968

    10 G Oct 28, 2025
    United States

    SR-14968

    10 G Oct 16, 2025
    United States

    SR-14968

    1 KG Jul 11, 2026
    United States

    Sr 14968

    1 G Jun 23, 2026
    United States

    Sr-14968

    10 G May 6, 2026
    United States

    Sr-14968

    10 G May 2, 2026
    United States

    SR14968

    10 G Apr 30, 2026
    United States

    SR 14968

    10 G Mar 10, 2026
    United States

    sr 14968

    25 G Jan 29, 2026
    Germany

    SR 14968

    500 G Aug 9, 2025
    United States

    Sr-14968

    10 G May 4, 2026
    United States

    SR-14968

    300 G Apr 9, 2026
    United States

    SR-14968

    10 G Feb 28, 2026
    • 1
    • 2
    • Go to Page Go
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.